Private Equity

The strategic acquisition of Dignitas Technologies positions By Light to dominate the military simulation market, enhancing DoD readiness for future conflicts.

A new partnership brings institutional-grade private markets data from Hamilton Lane to financial advisors, aiming to demystify alternative investments.

A 79-unit building sale in St. Catharines marks a new investor's arrival, highlighting a trend targeting Southwestern Ontario's rental markets.

A new lawsuit claims private equity giant TPG hid implant defects and forced a bankruptcy, leaving thousands of injured patients to pay the price.

A new survey shows most family firms expect a leadership change soon, but few are prepared, creating a high-stakes gap between intent and action.

In a major market shakeup, Dingdong is selling its China grocery operations to rival Meituan and plans to return the proceeds to shareholders.

Lithuanian manufacturer Eurodita's 'no minimum order' private-label plan could reshape Europe's construction market for independent dealers.

DFR Gold secures $1.2M in insider loans, pushing total debt to $4.5M. The funds aim to fast-track its Burkina Faso gold project, but is it a vote of confidence or a sign of financial strain?

A Canadian family-owned food manufacturer expands with a new facility and pasta line, capitalizing on the booming demand for ready-to-eat ingredients.

The advanced nuclear startup's new funding and partnership with Blue Owl signal a major push to solve the massive energy demands of data centers.

FPX Nickel's massive Baptiste project could supply low-carbon nickel for EVs, but it first needs to win over the public and regulators. Here's what's at stake.

The advisory giant's acquisition of a Boston-based specialist signals a strategic push into the high-stakes, high-growth world of life sciences and biotech.

With a new CEO from the plaintiff legal world, Practice Made Perfect aims to scale its unique model for law firm growth in an increasingly competitive market.

A new partnership between South Korea's GCCL and Europe's Medicover MICS promises to streamline drug development by creating a seamless East-West axis.

Following a landmark FDA approval, IceCure Medical's long-serving CFO is exiting, placing the company at a pivotal financial crossroads for its new treatment.

The BDC generated a robust 12.52% yield, but a $7.2M unrealized loss in equities pulled down its net asset value, painting a complex picture.

With its IPO complete, Cambridge Acquisition Corp. enters a disciplined SPAC market with a clear focus on wellness, hemp, and psychedelic tech targets.

Belgian biotech Agomab Therapeutics secures $200 million in its Nasdaq debut, fueling its mission to develop therapies for debilitating fibrotic conditions.

As Nordstrom marks 125 years, its year-long celebration is more than a party—it's a strategic move to bolster loyalty and adapt in a tough market.

Honda's landmark partnership with the iconic 6666 Ranch goes beyond branding, testing its rugged vehicles in the heart of authentic American ranching.